Kannaway made its debut on the European cannabigerol (CBG) market on Thursday by its parent company Medical Marijuana Inc. MJNA.
The move comes on the heels of Kannnaway's entering into the U.S. cannabinol market with the introduction of two new CBN isolate products.
Each bottle of Kannaway's newly released product contains 200 milligrams of CBD and 500 milligrams of CBG coming from European organic hemp.
Products are certified via the company's Triple Lab Testing process, the San Diego company confirmed.
"As CBD continues to grow in acceptance around the world, the market for cannabinoids like CBG also expands," noted Kannaway CEO Blake Schroeder. "Our company intends to continue to be at the forefront of expanding access to cannabinoids just as we have been with CBD."
Meantime, earlier this year, Kannaway tapped NHL and network marketing veteran Mike Hartman to its Sports Team to endorse CBD, and also Carolyn Dielmann Connolly as its new brand ambassador.
In January, Kannaway was named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list.
Courtesy image
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!